Cargando…

Ruthenium(II) and Platinum(II) Complexes with Biologically Active Aminoflavone Ligands Exhibit In Vitro Anticancer Activity

Continuing our studies on the mechanisms underlying the cytotoxicity of potential drugs, we have described several aspects of the in vitro anticancer activity of ruthenium(II) and platinum(II) complexes with bioactive, synthetic aminoflavone ligands. We examined the mechanism of proapoptotic activit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fabijańska, Małgorzata, Kasprzak, Maria M., Ochocki, Justyn
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8306828/ https://www.ncbi.nlm.nih.gov/pubmed/34299199 http://dx.doi.org/10.3390/ijms22147568

Ejemplares similares

Simple Trans-Platinum Complex Bearing 3-Aminoflavone Ligand Could Be a Useful Drug: Structure-Activity Relationship of Platinum Complex in Comparison with Cisplatin
por: Fabijańska, Małgorzata, et al.
Publicado: (2020)

New Look on 3-Hydroxyiminoflavanone and Its Palladium(II) Complex: Crystallographic and Spectroscopic Studies, Theoretical Calculations and Cytotoxic Activity
por: Kasprzak, Maria, et al.
Publicado: (2016)

Fluorimetric Properties of 3-Aminoflavone Biomolecule (3-AF). X-ray Crystal Structure of New Polymorph of 3-AF
por: Pająk, Wojciech, et al.
Publicado: (2019)

Bioorthogonal Catalytic Activation of Platinum and Ruthenium Anticancer Complexes by FAD and Flavoproteins
por: Alonso‐de Castro, Silvia, et al.
Publicado: (2018)

Photocytotoxic Activity of Ruthenium(II) Complexes with Phenanthroline-Hydrazone Ligands
por: Silva-Caldeira, Priscila Pereira, et al.
Publicado: (2021)

DNA-Binding Capabilities and Anticancer Activities of Ruthenium(II) Cymene Complexes with (Poly)cyclic Aromatic Diamine Ligands
por: Alsaeedi, Mona S., et al.
Publicado: (2020)

Ruthenium(II)/(III) DMSO-Based Complexes of 2-Aminophenyl Benzimidazole with In Vitro and In Vivo Anticancer Activity
por: Elsayed, Shadia A., et al.
Publicado: (2020)

Monofunctional Platinum(II) Anticancer Agents
por: Jin, Suxing, et al.
Publicado: (2021)

Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status
por: Wehbe, Mohamed, et al.
Publicado: (2017)

Influence of the π-coordinated arene on the anticancer activity of ruthenium(II) carbohydrate organometallic complexes
por: Hanif, Muhammad, et al.
Publicado: (2013)

Anticancer evaluation of new organometallic ruthenium(ii) flavone complexes
por: Khater, Mai, et al.
Publicado: (2022)

Novel Nickel(II), Palladium(II), and Platinum(II) Complexes with O,S Bidendate Cinnamic Acid Ester Derivatives: An In Vitro Cytotoxic Comparison to Ruthenium(II) and Osmium(II) Analogues
por: Hildebrandt, Jana, et al.
Publicado: (2022)

Combatting AMR: photoactivatable ruthenium(ii)-isoniazid complex exhibits rapid selective antimycobacterial activity
por: Smith, Nichola A., et al.
Publicado: (2017)

Studies of the Antiproliferative Activity of Ruthenium (II) Cyclopentadienyl-Derived Complexes with Nitrogen Coordinated Ligands
por: Moreno, Virtudes, et al.
Publicado: (2010)

Characterization of platinum(II) complexes exhibiting inhibitory activity against the 20S proteasome
por: Kiwada, Tatsuto, et al.
Publicado: (2020)

Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands
por: Sacco, Francesca, et al.
Publicado: (2021)

Cytotoxic (salen)ruthenium(iii) anticancer complexes exhibit different modes of cell death directed by axial ligands
por: Li, Cai, et al.
Publicado: (2017)

Cyclometalated Iminophosphorane Gold(III) and Platinum(II) Complexes. A Highly Permeable Cationic Platinum(II) Compound with Promising Anticancer Properties
por: Frik, Malgorzata, et al.
Publicado: (2015)

Synthesis, Spectroscopic Analysis and Assessment of the Biological Activity of New Hydrazine and Hydrazide Derivatives of 3-Formylchromone
por: Słomiak, Krzysztof, et al.
Publicado: (2018)

Radiosensitisation of human colorectal cancer cells by ruthenium(II) arene anticancer complexes
por: Carter, R, et al.
Publicado: (2016)

Ruthenium(II) and Iridium(III) Complexes as Tested Materials for New Anticancer Agents
por: Masternak, Joanna, et al.
Publicado: (2020)

Synthesis, Characterisation and In Vitro Permeation, Dissolution and Cytotoxic Evaluation of Ruthenium(II)-Liganded Sulpiride and Amino Alcohol
por: M’bitsi-Ibouily, Gretta C., et al.
Publicado: (2019)

The ruthenium compound KP1339 potentiates the anticancer activity of sorafenib in vitro and in vivo()
por: Heffeter, Petra, et al.
Publicado: (2013)

Light Stability, Pro-Apoptotic and Genotoxic Properties of Silver (I) Complexes of Metronidazole and 4-Hydroxymethylpyridine against Pancreatic Cancer Cells In Vitro
por: Żyro, Dominik, et al.
Publicado: (2020)

Asymmetric Ruthenium(II) and Osmium(II) Complexes with New Bidentate Polyquinoline Ligands. Synthesis and NMR Characterization
por: Mamo, Antonino, et al.
Publicado: (2010)

Bipyridine Ruthenium(II) Complexes with Halogen-Substituted Salicylates: Synthesis, Crystal Structure, and Biological Activity
por: Schoeller, Martin, et al.
Publicado: (2023)

Green‐Light Activation of Push–Pull Ruthenium(II) Complexes
por: Moll, Johannnes, et al.
Publicado: (2020)

Conjugates Containing Two and Three Trithiolato-Bridged Dinuclear Ruthenium(II)-Arene Units as In Vitro Antiparasitic and Anticancer Agents
por: Studer, Valentin, et al.
Publicado: (2020)

Antitumor Activity of Ruthenium(II) Terpyridine Complexes towards Colon Cancer Cells In Vitro and In Vivo
por: Savic, Maja, et al.
Publicado: (2020)

Platinum(II) Terpyridine Anticancer Complexes Possessing Multiple Mode of DNA Interaction and EGFR Inhibiting Activity
por: Li, Chaoyang, et al.
Publicado: (2020)

Synthesis, Characterization, and Anticancer Activity of Benzothiazole Aniline Derivatives and Their Platinum (II) Complexes as New Chemotherapy Agents
por: Islam, Md. Kamrul, et al.
Publicado: (2021)

In Vitro Evaluation of Biological and Anticancer Activities Exhibited by Five Varieties of Vitis vinifera L.
por: Darwiche, Linda, et al.
Publicado: (2023)

Enhanced Circularly Polarized Luminescence Activity in Chiral Platinum(II) Complexes With Bis- or Triphenylphosphine Ligands
por: Yang, Qian-Ying, et al.
Publicado: (2020)

New Palladium(II) and Platinum(II) Complexes Based on Pyrrole Schiff Bases: Synthesis, Characterization, X-ray Structure, and Anticancer Activity
por: Mbugua, Simon N., et al.
Publicado: (2020)

Synthesis, Spectroscopy, Light Stability, Single-Crystal Analysis, and In Vitro Cytotoxic Activity on HepG2 Liver Cancer of Two Novel Silver(I) Complexes of Miconazole
por: Stryjska, Karolina, et al.
Publicado: (2020)

New platinum(II) complexes with benzothiazole ligands
por: Carmona-Negrón, José A., et al.
Publicado: (2016)

Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions()
por: Legin, Anton A., et al.
Publicado: (2014)

Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands
por: Argăseală, Aura, et al.
Publicado: (2022)

Ligand Evolution in the Photoactivatable Platinum(IV) Anticancer Prodrugs
por: Huang, Jingjing, et al.
Publicado: (2022)

Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
por: Adhireksan, Zenita, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pih29dr5610ag55l2as1stk3fv